2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 147 filers reported holding 2SEVENTY BIO INC in Q2 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $15,930,703 | -29.5% | 4,137,845 | -2.0% | 0.00% | -25.0% |
| Q1 2024 | $22,586,539 | +17.3% | 4,221,783 | -6.4% | 0.00% | 0.0% |
| Q4 2023 | $19,252,576 | +567.1% | 4,508,800 | +512.4% | 0.00% | +300.0% |
| Q3 2023 | $2,886,077 | -82.4% | 736,244 | -54.7% | 0.00% | -75.0% |
| Q2 2023 | $16,437,430 | -7.8% | 1,624,252 | -7.1% | 0.00% | 0.0% |
| Q1 2023 | $17,824,725 | +81.0% | 1,747,522 | +66.2% | 0.00% | +100.0% |
| Q4 2022 | $9,849,210 | +63868.4% | 1,051,143 | -0.7% | 0.00% | -50.0% |
| Q3 2022 | $15,397 | +246.9% | 1,058,219 | +214.7% | 0.00% | +300.0% |
| Q2 2022 | $4,439 | -99.8% | 336,309 | +187.0% | 0.00% | – |
| Q1 2022 | $1,999,000 | -84.7% | 117,185 | -77.0% | 0.00% | -100.0% |
| Q4 2021 | $13,031,000 | – | 508,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 684,996 | $9,885,521 | 8.20% |
| Madison Avenue Partners, LP | 1,199,832 | $11,242,426 | 1.99% |
| Newtyn Management, LLC | 882,134 | $8,265,596 | 1.71% |
| AlphaCentric Advisors LLC | 180,000 | $1,686,600 | 1.67% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $13,201 | 1.48% |
| Casdin Capital, LLC | 1,850,000 | $17,334,500 | 1.34% |
| CHI Advisors LLC | 333,252 | $3,122,571 | 0.83% |
| Birchview Capital, LP | 59,833 | $561 | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 250,000 | $2,342,500 | 0.34% |
| EcoR1 Capital, LLC | 1,143,494 | $10,714,539 | 0.33% |